Artnature Inc.
Artnature Inc. (7823.T) Financial Performance & Income Statement Overview
Explore the financials of Artnature Inc. (7823.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Artnature Inc. (7823.T) Income Statement & Financial Overview
Explore comprehensive income reports for Artnature Inc. 7823.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $11.35B | $10.86B | $10.96B | $10.17B |
| Cost of Revenue | $3.77B | $3.63B | $3.70B | $3.55B |
| Gross Profit | $7.58B | $7.23B | $7.26B | $6.62B |
| Gross Profit Ratio | $0.67 | $0.67 | $0.66 | $0.65 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.95B | $6.83B | $6.55B | $6.23B |
| Operating Expenses | $6.95B | $6.83B | $6.51B | $6.23B |
| Total Costs & Expenses | $10.72B | $10.45B | $10.21B | $9.78B |
| Interest Income | $19.00M | $11.00M | $13.00M | $11.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $333.00M | $283.00M | $306.00M | $283.00M |
| EBITDA | $275.00M | $686.00M | $1.05B | $675.00M |
| EBITDA Ratio | $0.02 | $0.06 | $0.10 | $0.07 |
| Operating Income | $631.00M | $405.00M | $756.00M | $391.00M |
| Operating Income Ratio | $0.06 | $0.04 | $0.07 | $0.04 |
| Other Income/Expenses (Net) | -$691.00M | $72.00M | -$59.00M | -$8.00M |
| Income Before Tax | -$60.00M | $477.00M | $697.00M | $383.00M |
| Income Before Tax Ratio | -$0.005 | $0.04 | $0.06 | $0.04 |
| Income Tax Expense | $4.00M | $211.00M | $277.00M | $182.00M |
| Net Income | -$65.00M | $266.00M | $421.00M | $201.00M |
| Net Income Ratio | -$0.006 | $0.02 | $0.04 | $0.02 |
| EPS | -$2.03 | $8.04 | $12.95 | $6.18 |
| Diluted EPS | -$2.03 | $8.04 | $12.78 | $6.11 |
| Weighted Avg Shares Outstanding | $32.56M | $32.56M | $32.51M | $32.90M |
| Weighted Avg Shares Outstanding (Diluted) | $32.56M | $33.02M | $32.94M | $32.90M |
Over the past four quarters, Artnature Inc. demonstrated steady revenue growth, increasing from $10.17B in Q1 2024 to $11.35B in Q4 2024. Operating income reached $631.00M in Q4 2024, maintaining a consistent 6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $275.00M, reflecting operational efficiency. Net income dropped to -$65.00M, with EPS at -$2.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan